Oxidative stress is closely associated with
acetaminophen (
APAP)-induced toxicity.
Davallialactone (
DAVA), a
hispidin analog derived from the mushroom Inonotus xeranticus, has
antioxidant properties. This study evaluated whether
DAVA plays protective roles against
APAP hepatotoxicity in mice. Pretreatments with
DAVA (10 mg/kg) prior to exposures of mice to a hepatotoxic dose of 600 mg/kg
APAP significantly increased survival rate compared to
APAP alone. To verify this effect, mice were treated with 400 mg/kg
APAP 30 min after
DAVA administration and were then sacrificed after 0.5, 1, 3, and 6 h.
APAP alone caused severe liver
injuries as characterized by increased plasma GOT and GPT levels,
ATP and GSH depletion, and
peroxynitrite and 4-HNE formations. These liver damages induced by
APAP were significantly attenuated by
DAVA pretreatments. The GSH/
GSSG ratio nearly recovered to the levels observed in non-
APAP-treated mice at 6h after
APAP treatment in
DAVA-pretreated mice. Furthermore, while hepatic ROS levels were increased by
APAP exposures, pretreatments with
DAVA completely blocked ROS formation. In addition,
APAP-induced sustained activations of JNK and ERK were remarkably reduced by
DAVA pretreatment. In conclusion, these results suggest that
DAVA plays protective roles against
APAP-mediated hepatotoxicity through function as ROS scavenger.